Amgen said on Tuesday that its drug helped improve daily activities including chewing and swallowing in patients suffering ...

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

The AstraZeneca PLC ADR AZN slumped 0.35% to $76.87 Tuesday, on what proved to be an all-around favorable trading session for ...

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

Shares of AstraZeneca PLC AZN inched down 0.54% to £115.22 Tuesday, on what proved to be an all-around positive trading ...

The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

Committee for Medicinal Products for Human Use (CHMP) has recommended approving AstraZeneca’s Fasenra (benralizumab) to treat ...

The newly launched “What Science Can Do” campaign, a longstanding tagline for AstraZeneca, centers around the stories of two patients who have benefitted from the company’s therapeutics. Each of their ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.